The largest database of trusted experimental protocols

Sevoflurane

Sevoflurane is a volatile anesthetic agent used for induction and maintenance of general anesthesia.
It is characterized by a rapid onset and offset of action, making it a popular choice for surgical procedures.
Sevoflurane has a pleasant odor and low blood/gas partition coefficient, contributing to its wide use in pediatric and adult populations.
Researchers can optimize their Sevoflurane studies with PubCompare.ai, the leading AI platform for reproduceible and accurate research protocols.
PubCompare.ai provides access to Sevoflurane protocols from literature, preprints, and patents, and leverages AI-driven comparisons to identify the best protocols and products.
Experiance seamless research optimization with PubCompare.ai.

Most cited protocols related to «Sevoflurane»

Performance of the EPC was tested in awake behaving monkeys. Following initial training monkeys were implanted with a head holder, eye coil, and recording chambers above V1 under general anesthesia and sterile conditions. For the anesthesia animals were initially sedated with a 0.1 ml/kg ketamine intra-muscular injection (100 mg/ml). Thereafter, bolus injections of propofol were administered intra-venously to allow for tracheal intubation (0.05–0.1 ml). Prior to surgery a bolus injection of dexamethosone sodium phosphate was administered i.v. (0.33 mg/kg). During surgery anesthesia was maintained by gaseous anaesthetic (1–3% sevoflurane) combined with continuous i.v. application of an opioid analgesic (Alfentanil, 156 μg/kg/h). The animal's rectal temperature, heart rate, blood oxygenation and expired CO2 were continuously monitored during surgery. Immediately after surgery (and during the following 3–5 days) the animals were given antibiotics (Cephorex 0.5 ml/kg or Synolux 0.25 ml/kg) and analgesics (Metacam 0.1 ml/kg).
Following surgery the recording chambers were regularly cleaned under sterile conditions and 5-fluoro-uracil treatment was performed three times per week (Spinks et al., 2003 (link)). Despite 5-fluoro-uracil treatment it was necessary to perform dura scrapes every 6–8 weeks for the removal of fibrous scar tissue above the craniotomy.
All animal and surgical procedures were in accordance with the European Communities Council Directive 1986 (86/609/EEC), the National Institutes of Health guidelines for care and use of animals for experimental procedures, the Society for Neurosciences Policies on the Use of Animals and Humans in Neuroscience Research, and the UK Animals Scientific Procedures Act.
Full text: Click here
Publication 2006
Alfentanil Analgesics Analgesics, Opioid Anesthesia Anesthetic Gases Animals Antibiotics, Antitubercular BLOOD Cell Respiration Cicatrix Craniotomy Dura Mater Fibrosis Fluorouracil General Anesthesia Head Homo sapiens Intramuscular Injection Intubation, Intratracheal Ketamine Monkeys Operative Surgical Procedures Propofol Rate, Heart Rectum Sevoflurane sodium phosphate Sterility, Reproductive Tissues
The power spectral density, also referred to as the power spectrum or spectrum, quantifies the frequency distribution of energy or power within a signal. For example, figures 1A–B show representative electroencephalogram spectrograms under general anesthesia maintained with sevoflurane and propofol. In these spectrograms, frequencies are arranged along the y-axis, and time is along the x-axis, and power is indicated by color on a decibel (dB) scale. Figures 1C–D show selected 10-second epochs of raw encephalogram signals from time-points encompassed in figures 1A–B. Figures 1E–L show the 0.1–1 Hz, 1–4Hz, 4–8Hz and 8–14 Hz bandpass filtered electroencephalogram signals from figures 1C–D. We computed spectrograms using the multitaper method, implemented in the Chronux toolbox.21 We computed group-level spectrograms by taking the median across all patients. We also calculated the spectrum for the selected electroencephalogram epochs. The resulting power spectra were then averaged for all epochs, and 95% confidence intervals were computed via multitaper-based jackknife techniques.21 The spectral analysis parameters were: window length T = 2s with 0s overlap, time-bandwidth product TW = 3, number of tapers K = 5, and spectral resolution of 3 Hz. We estimated the peak power, and its frequency, of the frontal alpha oscillation for each individual subject. We then averaged across subjects to obtain the group-level peak power and frequency for these oscillations.
Publication 2014
Electroencephalography Epistropheus EPOCH protocol General Anesthesia Patients Propofol Sevoflurane
We performed the experiments in accordance with the National Institute of Health guidelines and regulations. The Massachusetts General Hospital Standing Committee on the Use of Animals in Research and Teaching (Boston, Massachusetts) has approved the animal protocol. We minimized the number of animals used in the studies. We employed both male and female WT mice (C57BL/6J, Jackson Lab, Bar Harbor, ME) and Tau KO mice (B6.129X1-Mapttm1Hnd/J, Jackson Lab) in the studies. We randomly assigned the mice into the anesthesia group or the control group. The mice received the sevoflurane at postnatal day (P)6 or from P6 to P8, and then were decapitated for hippocampus harvest at P6, P8, P10, and P31. We used different groups of mice for the behavioral testing from P31 to P35 or P37. The mice received anesthetic sevoflurane (3%) plus 60% oxygen (balanced with nitrogen) as performed in our previous studies 9 (link),50 (link). The findings from our previous studies have demonstrated that the 60% oxygen maintains sufficient partial pressure of oxygen levels in the mice during the sevoflurane anesthesia 5 (link),9 (link),50 (link). The size of the induction chamber in the current study was 20 × 20 × 7 centimeters. The induction flow rate was 2 liters per minute for the first three minutes (for the induction) and then one liter per minute (for maintenance). Control groups received 60% oxygen at an identical flow rate in similar chambers. We monitored the anesthetic and oxygen concentrations continuously with a gas analyzer (Ohmeda, GE Healthcare, Tewksbury, MA). The temperature of the anesthetizing chamber was controlled by the DC Temperature Control System (FHC, Bowdoinham, Maine), which is a feedback based system for monitoring and controlling temperature, to maintain the rectal temperature of the mice as 37 ± 0.5 °C. Previous studies 5 (link),9 (link),50 (link) have shown that anesthesia with 3% sevoflurane for two hours did not significantly change the values of pH, partial pressure of oxygen, or partial pressure of carbon dioxide as compared to the control group. The eating and drinking of mice between the control group and anesthesia group were assessed by the amount of food and water consumed and the changes in body weight. The general activity between the anesthesia mice and control mice was observed in a blind manner. There was less than 1% mortality rate of mice in the studies. For the intervention studies, we administrated lithium (100 mg/kg) 51 (link) to mice through intraperitoneal injection 30 minutes before each of the three days of the sevoflurane anesthesia. All of the experiments were performed in a blind manner.
Publication 2014
Anesthesia Anesthetics Animals Carbon dioxide Females Food General Anesthesia Injections, Intraperitoneal Lithium Males Mus Nitrogen Oxygen Partial Pressure Rectum Seahorses Sevoflurane Visually Impaired Persons
The animal protocol was approved by Standing Committee on Animals at Massachusetts General Hospital (Boston, Massachusetts). Naïve mice [C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME)] and AD transgenic mice [B6.Cg-Tg(APPswe, PSEN1dE9)85Dbo/J, (The Jackson Laboratory, Bar Harbor, ME)] were distinguished by genotyping. All animals (3 to 12 mice per experiment) were six days of age at the time of anesthesia and were randomized by weight and gender into experimental groups that received either 3% or 2.1% sevoflurane plus 60% oxygen for either six or two hours, and control groups that received 60% oxygen for six or two hours at identical flow rates in identical anesthetizing chambers. We chose this sevoflurane anesthesia because the recent study by Satomoto et al. 6 (link) indicated that anesthesia with 3% sevoflurane plus 60% oxygen for six hours does not significantly alter blood gas and brain blood flow, which is consistent with our pilot studies. The mortality rate of the mice following the anesthesia with 3% sevoflurane plus 60% oxygen for six hours in the current studies was about 10-15%, which could be due to the higher than clinically relevant concentration of sevoflurane. We used this high concentration of sevoflurane anesthesia to illustrate the difference of sevoflurane-induced neurotoxicity between neonatal naïve and AD transgenic mice. Moreover, we also assessed the effects of anesthesia with 2.1% sevoflurane, a more clinically relevant concentration of sevoflurane (which did not cause the death of the mice), on the effects of caspase-3 activation and Aβ levels in the brain tissues of neonatal mice. Anesthetic and oxygen concentrations were measured continuously (Datex, Tewksbury, MA), and the temperature of the anesthetizing chamber was controlled to maintain the rectal temperature of the mice at 37 ± 0.5°C. In the interaction studies, Inositol triphosphate receptor (IP3R) antagonist 2-aminoethoxydiphenyl borate (2-APB) (5 and 10 mg/kg) was administered to the mice via intraperitoneal injection 10 minutes before the anesthetic was administered. 2-APB was first dissolved in dimethyl sulfoxide to 20 μg/μl, and then diluted with saline to 0.25 μg/μl (1:80 dilution) to 0.5 μg/μl (1:40 dilution).
Publication 2010
Anesthesia Anesthetic Effect Anesthetics Animals BLOOD Borates Brain Brain Blood Flow Caspase 3 Infant, Newborn Injections, Intraperitoneal ITPR1 protein, human Mice, Inbred C57BL Mice, Laboratory Mice, Transgenic Neurotoxicity Syndromes Oxygen Rectum Saline Solution Sevoflurane Sulfoxide, Dimethyl Technique, Dilution Tissues Triphosphate Receptor, Inositol

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2018
Acetylcholine Anesthesia Brain Carbachol Dialysis Solutions Electroencephalography EPOCH protocol High-Performance Liquid Chromatographies Mass Spectrometry Norepinephrine Obstetric Delivery Perfusion Rate, Heart Rattus norvegicus Respiration Respiratory Rate Sevoflurane Student

Most recents protocols related to «Sevoflurane»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Arteries brusatol celastrol Internal Carotid Arteries Mice, House Middle Cerebral Artery Middle Cerebral Artery Occlusion Operative Surgical Procedures physiology Reperfusion Saline Solution Sevoflurane Thyroid Gland
The in vitro cytotoxicity assay of the purified protease of S. typhimurium against HT29 human adenocarcinoma cell line (Merck, Darmstadt, Germany) was performed on a 96-well plate by incubation for 24 h. Per 1 × 105 HT29 cells per milliliter, fifteen micrograms of the enzyme were used. By the end of incubation, the percent of cell death of HT29 was assessed by the standard MTT assay16 (link). For negative blanks, physiological saline was used instead of the active protease preparations, while for blanks, a medium without cells was used. The idea of this assay is that the remaining surviving cells can convert the yellow tetrazolium MTT reagent into the purple formazan complex with a characteristic absorption at A540 nm, therefore indicating HT29 viability. The intensity of the purple color is in direct relation to the number of surviving cells after exposure to the UcB5.
Furthermore, an assay of cell-damaging activity against RBCs (hemolytic activity) due to the purified enzyme was done. This was achieved by vortexing identical volume sizes of 15 µg protease/mL and 4% (v/v) washed human RBCs suspended in 0.1 M borate buffer, pH 7.5. Incubation was done at 37 °C for 90 min, thereafter, the quantity of released hemoglobin was measured colorimetrically. For comparison, a complete hemolysis treatment was done by mixing RBCs suspension with 1% (v/v) triton X-100 solution.
Also, an in vivo screening of cell-damaging activity was done and the LD50 value was calculated. For this, BALB/c mice weighing 22–25 g were acclimatized to the laboratory conditions for one week and retained at relatively fixed nutritional and physical conditions. They were then divided into six groups of six per cage. The first group was represented as the universal blank group. Mice in this group were intraperitoneally inoculated with an equal volume of a heat-denatured enzyme preparation at a concentration of 60 µg/body weight. While the other five groups were intraperitoneally injected with the active protease preparation at various concentrations (60, 30, 15, 8, and 4 µg protease/body weight) in a total volume of 1 ml solution. Animals were then observed at time intervals throughout 48 h for the LD50 calculation according to the method of Karber. Livers of affected and blank mice were removed instantly after death and fixed in 5% (v/v) glutaraldehyde then 1% (w/v) OsO4 solution. Before dissection of a blank mouse, it was anaesthsized by the inhalant gas sevoflurane. Ultrathin sections of 70 nm were sliced by RMC ultramicrotome and loaded on standard-grade TEM support grids made-up of copper for examination under JEOL 1010 TEM.
Full text: Click here
Publication 2023
Adenocarcinoma Animals Biological Assay Body Weight Borates Buffers Cell Death Cell Lines Cells Copper Cytotoxin Dissection Enzymes Erythrocytes Formazans Glutaral Hemoglobin Hemolysis Homo sapiens HT29 Cells Inhalation Drug Administration Liver Mice, Inbred BALB C MTT formazan MTT tetrazolium Mus Peptide Hydrolases PER1 protein, human Physical Examination physiology protease S Saline Solution Sevoflurane Tetrazolium Salts Triton X-100 Ultramicrotomy
In Yuan et al study,[29 (link)] patients received standardized general anesthesia and basic analgesic protocol. Intraoperatively, all patients received general anesthesia which was induced by sufentanil 0.5 μg/kg, midazolam 0.04 mg/kg, propofol 1 to 2 mg/kg, and Cisatracurium 2 μg/kg intravenously, followed by continuous intravenous infusion of remifentanil 0.1 to 0.3 μg/(kg·min), propofol 2 to 5 mg/(kg·hr) and inhalation of sevoflurane to maintain anesthesia. Since postoperative day 1, the protocol of oral celecoxib restarted till postoperative 3 weeks when the patients came back to the hospital for taking out the stitches. In Yadeau et al 2016 study,[6 (link)] patients received a standardized anesthetic and multimodal analgesic protocol. In Yadeau et al 2022 study,[28 (link)] patients received a standard intraoperative and postoperative multimodal anesthetic protocol: a spinal-epidural (subarachnoid mepivacaine, 45–60 mg); adductor canal block (ultrasound-guided; 15 cc bupivacaine, 0.25%, with 2 mg preservative-free dexamethasone). For postoperative pain management, patients were scheduled to receive the study medication once daily for 14 days; 4 doses of 1000 mg IV acetaminophen every 6 hours followed by 1000 mg oral acetaminophen every 8 hours; 4 doses of 15 mg IV ketorolac followed by 15 mg meloxicam every 24 hours; and 5 to 10 mg oral oxycodone was given as needed for pain. Patients could have pain medications adjusted as indicated. In Koh et al study,[12 (link)] all patients had a postoperative intravenous patient-controlled anesthesia (PCA) pump that administered 1 mL of a 100-mL mixture containing 2000 mg of fentanyl on demand. In Kim et al study,[27 ] all patients received intravenous PCA encompassing delivery of 1 mL of a 100 mL solution containing 2000 µg of fentanyl postoperatively. In Ho et al study,[26 (link)] patients were routinely offered a single shot spinal anesthesia consisting of an intrathecal dose of bupivacaine 10 to 12.5 mg with fentanyl 10 mg. After surgery, pain treatment consisted of PCA with intravenous injection of morphine. The settings were 1 mg bolus, 5 minutes lockout time, and a maximum hourly limit of 8 mg. All patients were also given acetaminophen 1 g 6 hourly.
Publication 2023
Acetaminophen Analgesics Anesthesia Anesthesia, Intravenous Anesthetics Bupivacaine Cardiac Arrest Celecoxib cisatracurium Dexamethasone Fentanyl General Anesthesia Inhalation Intravenous Infusion Ketorolac Management, Pain Meloxicam Mepivacaine Midazolam Morphine Multimodal Imaging Obstetric Delivery Operative Surgical Procedures Oxycodone Pain Pain, Postoperative Patients Pharmaceutical Preparations Pharmaceutical Preservatives Propofol Pulp Canals Remifentanil Sevoflurane Spinal Anesthesia Subarachnoid Space Sufentanil Ultrasonography
The patients received their usual cardiac medications in the early morning on the day of surgery. Upon arriving OR, the patients were premedicated with midazolam 0.02 mg/kg and fentanyl 1 mcg/kg. A five-lead EKG, pulse oximetry, and noninvasive blood pressure monitoring were initiated. Then, we inserted a catheter into the radial artery under local anesthesia for invasive blood pressure monitoring. General anesthesia induction consisted of fentanyl 5–10 mcg/kg, midazolam 0.2–0.4 mg/kg, and pancuronium 0.1–0.15 mg/kg. Additionally, propofol 0.5–1 mg/kg was administered as appropriate. After intubation, we inserted a right internal jugular multilumen central venous catheter. Maintenance of anesthesia was with sevoflurane 1%–2%, adjusted by clinical conditions and pancuronium as needed.
Publication 2023
Anesthesia Arteries, Radial Blood Pressure Catheters Fentanyl General Anesthesia Heart Intubation Local Anesthesia Midazolam Oximetry, Pulse Pancuronium Patients Pharmaceutical Preparations Propofol Sevoflurane Surgery, Day Training Programs Venous Catheter, Central
All patients received general anesthesia, either alone or in combined with regional nerve block (including paravertebral nerve block, epidural anesthesia, and intercostal nerve block.) according to the type of surgery. Patients underwent lobectomy or sublobectomy according to surgeon’s comprehensive evaluation based on patient’s condition.
Anesthesia induction used propofol and/or etomidate, sufentanil, and rocuronium or cisatracurium. Anesthesia maintenance used sevoflurane or propofol combined with remifentanil or sufentanil. Rocuronium or cisatracurium was used to maintain muscle relaxation. Supplemental drugs such as flurbiprofen axetil were administered when necessary. The aim was to maintain BIS 40-60, blood pressure within 20% of baseline, and temperature 36-37°C.
Double-lumen endotracheal tube of sizes Ch33-39 was used for lung isolation according to patient height. The ventilation mode was volume control mode with 6-8 ml/kg of tidal volume (TV) during two-lung ventilation and 5-6 ml/kg during one-lung ventilation (OLA), and 0-5 cmH2O of positive end-expiratory pressure (PEEP), and 12-20 breaths/min of respiratory rates. The aim was to maintain PETCO2 35-45 mmHg and SpO2 ≥92%. At the end of anesthesia, neostigmine was used to antagonize muscular relaxant before extubation.
Fluid infusion was administrated with crystalloid at a rate of 4–6 mL/kg-1h-1. Colloids or blood product was used according to anesthesiologist’s comprehensive evaluation based on patient’s condition. Patient-controlled intravenous analgesia was used after surgery for postoperative analgesia to maintain numeric rating scales (NRS) ≤ 3 scores.
Full text: Click here
Publication 2023
Anesthesia Anesthesiologist BLOOD Blood Pressure cisatracurium Colloids Epidural Anesthesia Etomidate flurbiprofen axetil General Anesthesia isolation Lung Management, Pain Muscle Tissue Neostigmine Nerve Block One-Lung Ventilation Operative Surgical Procedures Patient-Controlled Analgesia Patients Pharmaceutical Preparations Positive End-Expiratory Pressure Propofol Relaxations, Muscle Remifentanil Respiratory Rate Rocuronium Saturation of Peripheral Oxygen Sevoflurane Solutions, Crystalloid Sufentanil Surgeons Tidal Volume Tracheal Extubation

Top products related to «Sevoflurane»

Sourced in United States, Germany, Sweden, United Kingdom, China, Israel, Spain, Japan
Sevoflurane is an inhaled anesthetic agent manufactured by Abbott Laboratories. It is a clear, colorless, and volatile liquid used in the administration of general anesthesia. Sevoflurane provides anesthetic and analgesic effects, allowing for the induction and maintenance of a patient's anesthetic state during surgical procedures.
Sourced in Germany, United States, Switzerland, United Kingdom, Spain
Sevorane is a volatile anesthetic agent manufactured by Abbott. It is used for the induction and maintenance of general anesthesia.
Sourced in United States, Germany, United Kingdom
Sevoflurane is a volatile anesthetic agent used in laboratory settings. It is a colorless, sweet-smelling liquid that is commonly used for the induction and maintenance of general anesthesia. Sevoflurane is known for its rapid onset and recovery times, making it a widely-used choice in various laboratory procedures and experiments.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, Germany, Denmark
Sevoflurane is a volatile anesthetic agent used in medical settings. It is a clear, colorless, and stable liquid that vaporizes at room temperature. Sevoflurane is primarily used for the induction and maintenance of general anesthesia.
Sourced in Japan
Sevoflurane is a volatile anesthetic agent used for the induction and maintenance of general anesthesia. It is a halogenated ether compound that acts on the central nervous system to produce a state of unconsciousness and insensibility to pain.
Sourced in United Kingdom, United States, Denmark
Sevorane is a volatile anesthetic agent used in the medical field. It is designed for the induction and maintenance of general anesthesia.
Sourced in Japan, United States
Sevoflurane is an inhalation anesthetic used in medical procedures. It is a colorless, volatile liquid that is administered through an anesthesia machine. Sevoflurane's core function is to induce and maintain general anesthesia in patients undergoing surgical or other medical procedures.
Sourced in United States, China
Sevoflurane is a volatile anesthetic agent used in the medical field. It is a clear, colorless, and non-flammable liquid used for the induction and maintenance of general anesthesia.
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.

More about "Sevoflurane"

Sevoflurane, also known as Sevorane, is a widely used volatile anesthetic agent that plays a crucial role in the induction and maintenance of general anesthesia.
This inhaled anesthetic is characterized by its rapid onset and offset of action, making it a popular choice for various surgical procedures, particularly in pediatric and adult populations.
One of the key advantages of Sevoflurane is its pleasant odor and low blood/gas partition coefficient, which contribute to its widespread use.
Researchers can optimize their Sevoflurane studies by leveraging the capabilities of PubCompare.ai, the leading AI platform for reproducible and accurate research protocols.
PubCompare.ai provides researchers with access to a comprehensive database of Sevoflurane protocols from literature, preprints, and patents.
By utilizing the platform's AI-driven comparison tools, researchers can identify the best protocols and products, ensuring seamless research optimization and improved outcomes.
In addition to Sevoflurane, researchers may also encounter related terms such as FBS (Fetal Bovine Serum) and Penicillin/Streptomycin, which are commonly used in cell culture and experimental procedures.
PubCompare.ai can assist researchers in navigating these related concepts and integrating them into their Sevoflurane studies for a more holistic and informed approach.
By harnessing the power of PubCompare.ai, researchers can streamline their Sevoflurane-related investigations, enhance reproducibility, and make more informed decisions, ultimately leading to advancements in the field of anesthesia and patient care.